Place of Jugular Ultrasound in the Evaluation of the Volemia by a Clinician Doctor in Routine Care

Not Applicable

Completed

• Conditions: Transfusion
• Interventions: Other: Jugular ultrasound

• Registration Number: NCT03484052
• Lead Sponsor: Rennes University Hospital

Brief Summary

Interventional study with minimal risks and constraints, prospective, monocentric.

Detailed Description

To appreciate the volemia of a patient is a frequent problem in hospital in various situations: renal insufficiency, dyspnea, dysnatremia, etc. The aging of the population, the chronicity of pathologies, overweight among other causes can make it difficult to assess the volume of the disease by the clinic alone. The consequences of a poor evaluation are delayed management and possible iatrogeny.

New discrimination markers have emerged to help the clinician such as "brain natriuretic peptide (BNP)" in dyspnea, and especially transthoracic echocardiography (TTE) assessing filling pressures with a high potency. discrimination. In current practice the TTE has unequal accessibility, and requires trained practitioners. It is difficult to have an TTE performed for all patients where the question arises.

Just as an assessment of the initial volemia is often necessary, there are few objective monitoring criteria. One can quote the variation of the weight or the evolution of certain biological parameters but none is completely specific.

A new marker has been described for a few years: jugular ultrasound. Better accessibility (requires only a probe of 7-9Hz, possibly 5Hz), it can indeed be performed by any practitioner in less than a minute. The jugular distension is a reflection of cardiac pre-load and can be correctly estimated by ultrasound. It has been shown that cardiac decompensated patients have dilated jugular veins compared to a reference population. A low cohort also demonstrated the presence of jugular ultrasound distension in the absence of clinical distension.

In a US study, 119 patients admitted to the emergency department for dyspnea had a sensitivity of 99% for a specificity of 59% for trans-jugular ultrasound in cardiogenic edema.

However, many applications remain to be explored, and the repeated use of jugular ultrasound in the same patient has never been studied. The accessibility of the measure could make it an excellent monitoring tool.

As a clinical situation, the investigators chose a well standardized and studied situation such as blood transfusion that can bridge the preload measured by invasive measures and measured by jugular ultrasound. This situation is complicated in patients in 1 to 5.7% of the situations of secondary pulmonary overload.

Study Timeline

• Study First Submitted: 2018-03-16
• Study First Submitted QC: 2018-03-29
• Study First Posted: 2018-03-30
• Study Start: 2018-05-15
• Primary Completion: 2018-08-23
• Study Completion: 2018-08-23
• Status Verified: 2023-05
• Last Update Submitted: 2023-05-22
• Last Update Posted: 2023-05-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• Major patient;
• Requiring a transfusion of 2 or more red blood cells in a routine care situation (transfusion programmed in the context of a day hospital or a traditional hospitalization, except in cases of massive bleeding);
• Affiliate or beneficiary of a social protection scheme;
• Having given his written consent.

Exclusion Criteria

• Patient with clinical or biological criteria for admission to intensive care as defined in the 1999 US ICU Practice Guidelines;
• Major persons subject to legal protection (legal safeguards, guardianship, tutorship), persons deprived of their liberty;
• Pregnant or lactating woman

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Jugular ultrasound	Jugular ultrasound	-

Primary Outcome Measures

Name	Time	Method
Evaluation of the volemia	Baseline	Variation in height of the area where the right jugular vein collapses in centimeters from the angle of Louis.

Secondary Outcome Measures

Name	Time	Method
Interobserver variability	Baseline	Inter-observer variability evaluated by the Bland and Altman graph.
Transfusion tolerance	Day 3	Study of transfusion tolerance (pre- and post-transfusion clinical collection, oral interview on D3 with the patient).
Semi-quantitative measurement variation in the height of the zone where the right jugular vein colludes	Baseline	The semi-quantitative variation in height measurement will be evaluated by a Chi² test or an exact Fisher test in two ways: improvement observed or no improvement observed

Trial Locations

Locations (1)

Rennes University Hospital; 🇫🇷 Rennes, Britain, France